Page last updated: 2024-12-06

4-methyl-1-phenylpentan-2-ol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID62661
CHEMBL ID3187810
CHEBI ID197064
SCHEMBL ID105502
MeSH IDM0118005

Synonyms (52)

Synonym
benzeneethanol, .alpha.-(2-methylpropyl)-
iso-butyl benzyl carbinol
alpha-isobutylphenethyl alcohol
brn 3243559
benzeneethanol, alpha-(2-methylpropyl)-
einecs 231-939-6
fema no. 2208
benzylisoamyl alcohol
alpha-(2-methylpropyl)benzeneethanol
4-methyl-1-phenylpentan-2-ol
isobutyl benzyl carbinol
2-methylpropyl benzyl carbinol
phenethyl alcohol, alpha-isobutyl-
isobutylbenzylcarbinol
alpha-isobutylphenethyl alcohol, 98%
M2012
4-methyl-1-phenyl-2-pentanol
7779-78-4
FT-0692535
CHEBI:197064
4-methyl-1-phenyl-pentan-2-ol
A839198
NCGC00256788-01
dtxcid1027710
tox21_302657
dtxsid8047717 ,
cas-7779-78-4
unii-2sbl0e1i0n
2sbl0e1i0n ,
4-06-00-03421 (beilstein handbook reference)
mfcd00209515
AKOS010016533
phenethyl alcohol, .alpha.-isobutyl-
.alpha.-isobutylphenethyl alcohol
.alpha.-isobutylphenethyl alcohol [fhfi]
2-pentanol, 4-methyl-1-phenyl-
SCHEMBL105502
4-methyl-1-phenyl-2-pentanol #
IUADYGVMSDKSMB-UHFFFAOYSA-N
2-pentanol, 4-methyl-1-phenyl
CHEMBL3187810
benzeneethanol,a-(2-methylpropyl)-
alpha-(2-methylpropyl)-benzeneethanol
a-(2-methylpropyl)benzeneethanol, 9ci
alpha-isobutyl-phenethyl alcohol
fema 2208
benzylisobutylcarbinol
BS-17588
Q27255540
D91564
CS-0154247
SY052681
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency48.96620.000214.376460.0339AID720692
estrogen nuclear receptor alphaHomo sapiens (human)Potency54.71190.000229.305416,493.5996AID743069; AID743079
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's5 (38.46)24.3611
2020's2 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.74 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.69%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (7.69%)0.25%
Other10 (76.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]